Immune profiling of circulating T cells and TILs following neoadjuvant ipilimumab and chemotherapy in non-small cell lung cancer (NSCLC).
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke Medical Center, Duke University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2796665220
